Rapid Micro Biosystems to Participate in Upcoming Investor Conferences
Rapid Micro Biosystems (Nasdaq: RPID), a life sciences technology company specializing in automation solutions for healthcare product manufacturing, has announced its participation in two upcoming investor conferences.
The company will deliver a presentation at the TD Cowen 45th Annual Health Care Conference on March 4, 2025, at 11:10 a.m. ET in Boston, Massachusetts. Additionally, RPID will participate in a Q&A session at the KeyBanc Capital Markets Healthcare Forum, a virtual event scheduled for March 19, 2025, at 11:15 a.m. ET.
Both events will be accessible via live webcasts on the company's investor relations website at investors.rapidmicrobio.com, with recordings available for replay after the events.
Rapid Micro Biosystems (Nasdaq: RPID), un'azienda tecnologica nel settore delle scienze della vita specializzata in soluzioni di automazione per la produzione di prodotti sanitari, ha annunciato la sua partecipazione a due prossime conferenze per investitori.
L'azienda presenterà un intervento alla 45a Conferenza Annuale sulla Salute di TD Cowen il 4 marzo 2025, alle 11:10 ET a Boston, Massachusetts. Inoltre, RPID parteciperà a una sessione di domande e risposte al Forum Sanitario di KeyBanc Capital Markets, un evento virtuale programmato per il 19 marzo 2025, alle 11:15 ET.
Entrambi gli eventi saranno accessibili tramite webcast dal vivo sul sito web delle relazioni con gli investitori dell'azienda all'indirizzo investors.rapidmicrobio.com, con registrazioni disponibili per la riproduzione dopo gli eventi.
Rapid Micro Biosystems (Nasdaq: RPID), una empresa de tecnología en ciencias de la vida especializada en soluciones de automatización para la fabricación de productos de salud, ha anunciado su participación en dos próximas conferencias para inversores.
La empresa realizará una presentación en la 45ª Conferencia Anual de Salud de TD Cowen el 4 de marzo de 2025, a las 11:10 a.m. ET en Boston, Massachusetts. Además, RPID participará en una sesión de preguntas y respuestas en el Foro de Salud de KeyBanc Capital Markets, un evento virtual programado para el 19 de marzo de 2025, a las 11:15 a.m. ET.
Ambos eventos serán accesibles a través de transmisiones en vivo en el sitio web de relaciones con inversores de la empresa en investors.rapidmicrobio.com, con grabaciones disponibles para su reproducción después de los eventos.
Rapid Micro Biosystems (Nasdaq: RPID)는 의료 제품 제조를 위한 자동화 솔루션을 전문으로 하는 생명 과학 기술 회사로, 두 개의 다가오는 투자자 회의에 참여할 것이라고 발표했습니다.
회사는 2025년 3월 4일 오전 11시 10분 ET에 매사추세츠주 보스턴에서 열리는 TD Cowen 제45회 연례 건강 관리 회의에서 발표를 진행합니다. 또한 RPID는 2025년 3월 19일 오전 11시 15분 ET에 예정된 가상 이벤트인 KeyBanc Capital Markets 건강 관리 포럼에서 질의응답 세션에 참여할 것입니다.
두 이벤트 모두 회사의 투자자 관계 웹사이트인 investors.rapidmicrobio.com에서 실시간 웹캐스트를 통해 접근할 수 있으며, 이벤트 후 재생 가능한 녹화도 제공됩니다.
Rapid Micro Biosystems (Nasdaq: RPID), une entreprise de technologie dans le domaine des sciences de la vie spécialisée dans les solutions d'automatisation pour la fabrication de produits de santé, a annoncé sa participation à deux prochaines conférences pour investisseurs.
L'entreprise fera une présentation lors de la 45e Conférence Annuelle sur la Santé de TD Cowen le 4 mars 2025, à 11h10 ET à Boston, Massachusetts. De plus, RPID participera à une session de questions-réponses lors du Forum de Santé de KeyBanc Capital Markets, un événement virtuel prévu pour le 19 mars 2025, à 11h15 ET.
Les deux événements seront accessibles par le biais de webdiffusions en direct sur le site web des relations avec les investisseurs de l'entreprise à l'adresse investors.rapidmicrobio.com, avec des enregistrements disponibles pour une rediffusion après les événements.
Rapid Micro Biosystems (Nasdaq: RPID), ein Technologieunternehmen im Bereich der Lebenswissenschaften, das sich auf Automatisierungslösungen für die Herstellung von Gesundheitsprodukten spezialisiert hat, hat seine Teilnahme an zwei bevorstehenden Investorenkonferenzen angekündigt.
Das Unternehmen wird am 4. März 2025 um 11:10 Uhr ET in Boston, Massachusetts, eine Präsentation auf der 45. jährlichen Gesundheitskonferenz von TD Cowen halten. Darüber hinaus wird RPID an einer Fragen-und-Antworten-Sitzung beim KeyBanc Capital Markets Healthcare Forum teilnehmen, einer virtuellen Veranstaltung, die für den 19. März 2025 um 11:15 Uhr ET geplant ist.
Beide Veranstaltungen werden über Live-Webcasts auf der Investor-Relations-Website des Unternehmens unter investors.rapidmicrobio.com zugänglich sein, mit Aufzeichnungen, die nach den Veranstaltungen zur Verfügung stehen.
- None.
- None.
LEXINGTON, Mass., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced that the Company will participate in the following investor conferences.
- TD Cowen 45th Annual Health Care Conference
Company presentation on Tuesday, March 4, 2025, at 11:10 a.m. ET in Boston, Massachusetts.
- KeyBanc Capital Markets Healthcare Forum (Virtual)
Question-and-answer session with the host analyst on Wednesday, March 19, 2025, at 11:15 a.m. ET.
Live webcasts for both events will be available on the Rapid Micro Biosystems investor relations website at https://investors.rapidmicrobio.com/ and can be accessed here. The webcast will be archived and available for replay after the event.
About Rapid Micro Biosystems
Rapid Micro Biosystems is an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The Company’s flagship Growth Direct system automates and modernizes the antiquated, manual microbial quality control (“MQC”) testing workflows used in the largest and most complex pharmaceutical manufacturing operations across the globe. The Growth Direct system brings the quality control lab to the manufacturing floor, unlocking the power of MQC automation to deliver the faster results, greater accuracy, increased operational efficiency, better compliance with data integrity regulations, and quicker decision making that customers rely on to ensure safe and consistent supply of important healthcare products. The Company is headquartered Lexington, Massachusetts and has U.S. manufacturing in Lowell, Massachusetts, with global locations in Switzerland, Germany, and the Netherlands. For more information, please visit www.rapidmicrobio.com or follow the Company on X (formerly known as Twitter) at @rapidmicrobio or on LinkedIn.
FAQ
When is Rapid Micro Biosystems (RPID) presenting at the TD Cowen Healthcare Conference 2025?
How can investors access RPID's upcoming March 2025 conference presentations?
What is the schedule for RPID's KeyBanc Capital Markets Healthcare Forum participation?
Will recordings of RPID's March 2025 investor conferences be available?
